All other professional, scientific and technical activities n.e.c.
NEXTA BIOTECH CONSULTING AS
Revenue 2025
NOK 3.0m
Operating profit
NOK 316,000
Equity
NOK 41,000
Incorporated
2024
Share capital
NOK 30,000
Key figures · 2025
Current ratio
1.05
Equity ratio
4.3%
Key figures over time · 2025
| Key figures | 2025 | Trend |
|---|---|---|
| Lønnsomhet | ||
| Operating margin (%%) | 10.4% | |
| Net margin (%%) | 8.1% | |
| Return on assets (%%) | 33.3% | |
| Likviditet | ||
| Current ratio | 1.05 | |
| Working capital | 41k | |
| Soliditet | ||
| Equity ratio (%%) | 4.3% | |
| Debt-to-equity ratio | 22.20 | |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.